We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Skinbiotherapeutics Plc | LSE:SBTX | London | Ordinary Share | GB00BF33H870 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.125 | 0.79% | 16.00 | 15.75 | 16.25 | 16.125 | 15.75 | 16.00 | 2,104,205 | 14:21:55 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 132k | -2.84M | -0.0125 | -12.80 | 35.89M |
Date | Subject | Author | Discuss |
---|---|---|---|
15/10/2024 00:18 | Just wondering, how many years if any is the operating lease on the BTS building ? What’s the long term lease liability there ? Thanks | kreature | |
14/10/2024 23:03 | Gleeful ping | thevladslayer | |
14/10/2024 22:54 | Talking of which, is there enough interest here? Whatever happened to elreeko and pals ? | kreature | |
14/10/2024 22:45 | Repayment : ‘ First 2 years quarterly interest payments, 3rd year quarterly interest and capital payments’ The third year might be heavy going then ? 237k every quarter plus the interest ? | kreature | |
14/10/2024 22:29 | Still looks like an interesting deal, but will there be any money left if you account for earn out of the foot rot, & interest payments & ebitda etc ? | kreature | |
14/10/2024 22:26 | Interesting …BTS sold for 1.25m Capital gains from zero at 24% would be £300k, leaving 950k, same as the cash loan | kreature | |
14/10/2024 22:14 | Makes it sound like there’s been loads of income from Croda ? Has there been any ? ‘ Having acquired BTS, the Group now has sufficient cash runway to support its operations through to Summer 2026 without any additional income from Croda or other joint development agreements. ‘ | kreature | |
14/10/2024 22:11 | Just says, interest 13%. Is it 13% per quarter, per year, or in total over 3 years ? | kreature | |
14/10/2024 22:07 | So have they got to pay back £1.3m (950k + £389k ) Does BTS turn a profit? : ‘ BTS reported unaudited revenues of £2.1 million and EBITDA of £0.5 million.’ What’s that without EBITDA ? Closer to zero I guess ? | kreature | |
14/10/2024 21:59 | ‘ In addition, the Company has entered into a subscription agreement with the same investor to subscribe for 2,349,624 new Ordinary Shares at 10.64p raising £250,000.’ Anyone know the terms of the subscription agreement? Subscribe when ? | kreature | |
14/10/2024 21:55 | ‘ The funds from the warrants on exercise will be used to reduce the debt from £950,000 to £600,000. ‘ Couldn’t they have had the warrants exercised before hand at lower price, then taken on less debt , or used cash in the bank ? | kreature | |
14/10/2024 21:42 | They had 1.9m in the bank so not sure they even needed a loan ? 13% interest plus 2% fees over 3 years ? Is that 13% per year ? I guess it must be £370k in interest to be paid ? Plus 2% fees (19,000) ? Total £389k ? Is that the going rate ? | kreature | |
14/10/2024 21:29 | I think so. And entitled to offload at the circa 13s distribution centre on the M1, so all that's left is a free holding before the next collapse.. Of course you need luck for that to occur when no news can do it. Or a maker that only understands instructions and not market | putinaire | |
14/10/2024 21:21 | Hmmm, well I’m buying more sub 10.6. That’s what it was worth to the investor, so I assume they dun the math ? | kreature | |
14/10/2024 18:10 | Bluuuuuuue | thevladslayer | |
14/10/2024 16:35 | Just want to thank Nobbygnome for telling us how a scam works | putinaire | |
14/10/2024 16:09 | 7.6 pct in a dayJob done ? | thevladslayer | |
14/10/2024 16:00 | Well that was a disappointing day. I thought we were going to the moon. Turns out we were only visiting the distribution centre haha | putinaire |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions